Open original FDA record ↗Recall record
- FDA identifier
- Z-2765-2026
- Company in FDA record
- Medline Industries, LP
- FDA classification date
- Jul 23, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class I
Reason stated in the source
The procedure kits contain ICU Medical, Inc. pain management kits containing Bupivacaine Hydrochloride in Dextrose Injection, USP, which were recalled due to quality issues that could result in drug ineffectiveness.
Source facts
- Action
- Medline Industries, LP issued an URGENT MEDICAL DEVCIE RECALL notice to its consignees on 6/8/2026 via email and USPS first class mail. The notice explained the issue and requested the following actions be taken: 1. Check stock and quarantine all affected product. 2. Use Website link: https://recalls.medline.com to respond. 3. Once response is received, Medline will send over-labels to affix to affected inventory (if applicable). 4. If the consignee further distributed or transferred the affected product, those to whom the product was sent are to be notified. For questions, contact the Recall Department at 866-359-1704 or recalls@medline.com.
- Initiated
- 2026-06-08
- Root cause
- Nonconforming Material/Component
- Distribution
- US: Mo, CO, IL
- Recall number
- Z-2765-2026
- Recall status
- Open, Classified
- CDRH record ID
- 221225
- FDA classified
- 2026-07-23
- Recall event number
- 99297